File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.3389/fendo.2022.957369
- WOS: WOS:000837107900001
Supplementary
-
Citations:
- Web of Science: 0
- Appears in Collections:
Article: Case Report: Insulinoma Co-Existing With Type 2 Diabetes – Advantages and Challenges of Treatment With Endoscopic Ultrasound-Guided Radiofrequency Ablation
Title | Case Report: Insulinoma Co-Existing With Type 2 Diabetes – Advantages and Challenges of Treatment With Endoscopic Ultrasound-Guided Radiofrequency Ablation |
---|---|
Authors | |
Issue Date | 2022 |
Citation | Frontiers in Endocrinology, 2022, v. 13 How to Cite? |
Abstract | The coexistence of insulinoma and type 2 diabetes is rare and the diagnostic process is often challenging. Continuous glucose monitoring system devices, which are more readily available nowadays, provide a useful tool for the diagnosis and evaluation of treatment response. Curative surgery is often the mainstay of treatment for insulinoma. Here, we report a Chinese patient with insulinoma diagnosed simultaneously with type 2 diabetes. His insulinoma was managed with endoscopic ultrasound guided-radiofrequency ablation (EUS-RFA) and the patient achieved complete resolution of hypoglycaemic episodes. The case illustrates that while EUS-RFA is an emerging non-invasive treatment modality for pancreatic lesions, limitations exist especially when histological confirmation is essential. |
Persistent Identifier | http://hdl.handle.net/10722/317835 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chang, JYC | - |
dc.contributor.author | Woo, CSL | - |
dc.contributor.author | Lui, TWD | - |
dc.contributor.author | Fung, MMH | - |
dc.contributor.author | Lee, ACH | - |
dc.contributor.author | Leung, EKH | - |
dc.contributor.author | Woo, YC | - |
dc.contributor.author | Chow, WS | - |
dc.contributor.author | Lam, KSL | - |
dc.contributor.author | Tan, KCB | - |
dc.contributor.author | Lee, CHP | - |
dc.date.accessioned | 2022-10-07T10:27:47Z | - |
dc.date.available | 2022-10-07T10:27:47Z | - |
dc.date.issued | 2022 | - |
dc.identifier.citation | Frontiers in Endocrinology, 2022, v. 13 | - |
dc.identifier.uri | http://hdl.handle.net/10722/317835 | - |
dc.description.abstract | The coexistence of insulinoma and type 2 diabetes is rare and the diagnostic process is often challenging. Continuous glucose monitoring system devices, which are more readily available nowadays, provide a useful tool for the diagnosis and evaluation of treatment response. Curative surgery is often the mainstay of treatment for insulinoma. Here, we report a Chinese patient with insulinoma diagnosed simultaneously with type 2 diabetes. His insulinoma was managed with endoscopic ultrasound guided-radiofrequency ablation (EUS-RFA) and the patient achieved complete resolution of hypoglycaemic episodes. The case illustrates that while EUS-RFA is an emerging non-invasive treatment modality for pancreatic lesions, limitations exist especially when histological confirmation is essential. | - |
dc.language | eng | - |
dc.relation.ispartof | Frontiers in Endocrinology | - |
dc.title | Case Report: Insulinoma Co-Existing With Type 2 Diabetes – Advantages and Challenges of Treatment With Endoscopic Ultrasound-Guided Radiofrequency Ablation | - |
dc.type | Article | - |
dc.identifier.email | Lui, TWD: dtwlui@hku.hk | - |
dc.identifier.email | Lam, KSL: ksllam@hku.hk | - |
dc.identifier.email | Tan, KCB: kcbtan@hkucc.hku.hk | - |
dc.identifier.email | Lee, CHP: pchlee@hku.hk | - |
dc.identifier.authority | Lui, TWD=rp02803 | - |
dc.identifier.authority | Lam, KSL=rp00343 | - |
dc.identifier.authority | Tan, KCB=rp00402 | - |
dc.identifier.authority | Lee, CHP=rp02043 | - |
dc.identifier.doi | 10.3389/fendo.2022.957369 | - |
dc.identifier.hkuros | 337181 | - |
dc.identifier.volume | 13 | - |
dc.identifier.isi | WOS:000837107900001 | - |